McKesson Hits Fresh 52W High as EPS Growth Accelerates
McKesson shares rose 1.40% to $994.58 on Oct. 30, trading near the top of a 52-week range that stretches from $723.68 to $1,030.27. The stock carries a trailing P/E of 24.58 on EPS of $37.35. Revenue grew 8.8% year over year, while EPS surged 49.1% — a pace that far outstrips the top line. Net margin sits at 1.1%, reflecting the thin-margin distribution model typical of pharmaceutical wholesalers. McKesson's Alpha Score of 54.6 is driven by momentum at 87.6 and quality at 62.2; value scores a below-average 26.7. The company's Q1 fiscal 2027 earnings call on Aug. 5 drew nine sell-side analysts, though the call transcript offered no new guidance. Watch for the next quarterly report, expected in early February, to see whether the EPS growth trajectory holds.